We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Johnson & Johnson (J&J) has appointed new members to its executive committee ahead of splitting its pharmaceuticals and over-the-counter consumer products businesses within the next two years. Read More
Roche has partnered with Recursion to generate up to 40 new neuroscience and cancer therapies using the Utah-based biotech firm’s machine-learning drug discovery platform. Read More
In the U.S., an FDA advisory committee narrowly backed authorizing molnupiravir last week, but the agency has yet to approve the COVID-19 pill for emergency use. Read More
Pfizer said Li uploaded over 12,000 documents to her personal drive and devices shortly before she was set to begin working at Xencor, a Monrovia, Calif.-based biotech. Read More
Philip Dormitzer provided Pfizer scientific leadership for the development of the company’s mRNA-based COVID-19 vaccine co-developed with BioNTech. Read More
A federal appeals court has upheld Mylan’s challenge to a Biogen patent covering the latter’s blockbuster multiple sclerosis (MS) drug Tecfidera (dimethyl fumarate). Read More
The new center is located near two large hospitals and a life sciences cluster that, with 400 companies, is the largest in Europe, AstraZeneca said. Read More